---
figid: PMC4676894__12943_2015_474_Fig3_HTML
figlink: /pmc/articles/PMC4676894/figure/Fig3/
number: Fig. 3
caption: 'Oncogenic (deregulated) intracellular signaling pathways in activated B
  cell-like (ABC) diffuse large B-cell lymphoma (DLBCL). The oncogenic constitutive
  activation of canonical nuclear factor-kappa B (NF-κB) family members in activated
  B cell-like diffuse large B-cell lymphoma (ABC-DLBCL), together with a blockade
  in terminal B cell differentiation, which is in part mediated by BCL6, represent
  the hallmarks of ABC-DLBCL pathogenesis [, –, ]. The different colors that are used
  in the figure indicate molecules that belong to a specific pathway and/or lead to
  a specific outcome. Adapted from REF: [, , , ]. Information for this figure was
  gleaned from the following references: [, , , , –, , , , , , –, , , , , , –, , ,
  , , , , , , , , , , –, –, , , , , –, –, –, , , , , –, –, , , ]. Abbreviations: BCR
  B cell receptor, BTK Bruton’s tyrosine kinase, SYK spleen tyrosine kinase, PI3K
  phosphoinositide 3-kinase, mTORC1 mammalian target of rapamycin (mTOR) complex 1,
  CD40L CD40 ligand, JAK Janus kinase, IRF4 interferon-regulatory factor 4, MALT1
  mucosa-associated lymphoid tissue lymphoma translocation protein 1, BCL10 B cell
  lymphoma protein 10, TLR Toll-like receptor, MyD88 myeloid differentiation primary
  response 88, CARD11 caspase recruitment domain family, member 11, PKCβ protein kinase
  Cβ, STAT3 signal transducer and activator of transcription 3, BCL6 B cell lymphoma
  protein 6, BCL2 B cell lymphoma protein 2'
pmcid: PMC4676894
papertitle: 'Novel drug targets for personalized precision medicine in relapsed/refractory
  diffuse large B-cell lymphoma: a comprehensive review.'
reftext: Rosalba Camicia, et al. Mol Cancer. 2015;14:207.
pmc_ranked_result_index: '191758'
pathway_score: 0.9748692
filename: 12943_2015_474_Fig3_HTML.jpg
figtitle: Oncogenic (deregulated) intracellular signaling pathways in activated B
  cell-like (ABC) diffuse large B-cell lymphoma (DLBCL)
year: '2015'
organisms: Homo sapiens
ndex: 8d1e784d-dec1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4676894__12943_2015_474_Fig3_HTML.html
  '@type': Dataset
  description: 'Oncogenic (deregulated) intracellular signaling pathways in activated
    B cell-like (ABC) diffuse large B-cell lymphoma (DLBCL). The oncogenic constitutive
    activation of canonical nuclear factor-kappa B (NF-κB) family members in activated
    B cell-like diffuse large B-cell lymphoma (ABC-DLBCL), together with a blockade
    in terminal B cell differentiation, which is in part mediated by BCL6, represent
    the hallmarks of ABC-DLBCL pathogenesis [, –, ]. The different colors that are
    used in the figure indicate molecules that belong to a specific pathway and/or
    lead to a specific outcome. Adapted from REF: [, , , ]. Information for this figure
    was gleaned from the following references: [, , , , –, , , , , , –, , , , , ,
    –, , , , , , , , , , , , , –, –, , , , , –, –, –, , , , , –, –, , , ]. Abbreviations:
    BCR B cell receptor, BTK Bruton’s tyrosine kinase, SYK spleen tyrosine kinase,
    PI3K phosphoinositide 3-kinase, mTORC1 mammalian target of rapamycin (mTOR) complex
    1, CD40L CD40 ligand, JAK Janus kinase, IRF4 interferon-regulatory factor 4, MALT1
    mucosa-associated lymphoid tissue lymphoma translocation protein 1, BCL10 B cell
    lymphoma protein 10, TLR Toll-like receptor, MyD88 myeloid differentiation primary
    response 88, CARD11 caspase recruitment domain family, member 11, PKCβ protein
    kinase Cβ, STAT3 signal transducer and activator of transcription 3, BCL6 B cell
    lymphoma protein 6, BCL2 B cell lymphoma protein 2'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - TRA
  - STAT3
  - CD79B
  - MYC
  - IFNA1
  - IFNA2
  - IFNA4
  - SYK
  - TRD
  - IFNA16
  - CD79A
  - PIK3R4
  - AKT3
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - BCL2
  - CARD11
  - TRB
  - IFNA8
  - TRG
  - CD2
  - CD40
  - CD40LG
  - CD58
  - IL10
  - IL6
  - IRAK4
  - IRF4
  - IFNA5
  - BCL6
  - BCR
  - MYD88
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA17
  - IFNA21
  - JAK1
  - IFNA6
  - AKT1
  - AKT2
  - NFKB1
  - TP53
  - IFNA7
  - MALT1
  - BCL10
  - PIK3R6
  - PIK3R5
  - MTOR
  - RPTOR
  - JAK2
  - Cancer
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: CD79A/B
  symbol: CD79B
  source: hgnc_symbol
  hgnc_symbol: CD79B
  entrez: '974'
- word: c-MYC
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: IFNa/ß
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IFNa/ß
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA2
  entrez: '3440'
- word: IFNa/ß
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: SYK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: IFNa/ß
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA16
  entrez: '3449'
- word: CD79A/B
  symbol: CD79A
  source: hgnc_symbol
  hgnc_symbol: CD79A
  entrez: '973'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: BCL2
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: CARD11
  symbol: CARD11
  source: hgnc_symbol
  hgnc_symbol: CARD11
  entrez: '84433'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: IFNa/ß
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: CD2
  symbol: CD2
  source: hgnc_symbol
  hgnc_symbol: CD2
  entrez: '914'
- word: CD40
  symbol: CD40
  source: hgnc_symbol
  hgnc_symbol: CD40
  entrez: '958'
- word: CD40L
  symbol: CD40L
  source: hgnc_alias_symbol
  hgnc_symbol: CD40LG
  entrez: '959'
- word: CD58
  symbol: CD58
  source: hgnc_symbol
  hgnc_symbol: CD58
  entrez: '965'
- word: IL6/10
  symbol: IL10
  source: hgnc_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: IL6/10R
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IRAK4
  symbol: IRAK4
  source: hgnc_symbol
  hgnc_symbol: IRAK4
  entrez: '51135'
- word: IRF4
  symbol: IRF4
  source: hgnc_symbol
  hgnc_symbol: IRF4
  entrez: '3662'
- word: IFNa/ß
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA5
  entrez: '3442'
- word: BCL6
  symbol: BCL6
  source: hgnc_symbol
  hgnc_symbol: BCL6
  entrez: '604'
- word: BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: MYD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: IFNa/ß
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA10
  entrez: '3446'
- word: IFNa/ß
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA13
  entrez: '3447'
- word: IFNa/ß
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA14
  entrez: '3448'
- word: IFNa/ß
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA17
  entrez: '3451'
- word: IFNa/ß
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA21
  entrez: '3452'
- word: JAK1/2
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: IFNa/ß
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA6
  entrez: '3443'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: IFNa/ß
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA7
  entrez: '3444'
- word: MALT1
  symbol: MALT1
  source: hgnc_symbol
  hgnc_symbol: MALT1
  entrez: '10892'
- word: BCL10
  symbol: BCL10
  source: hgnc_symbol
  hgnc_symbol: BCL10
  entrez: '8915'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: JAK1/2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
